H.R. 6513 · 117th Congress
Medical Innovation Acceleration Act of 2022
- Stage
- In committee
- Sponsor
- Andy Biggs
- Introduced
- 2022-01-28
- Latest action
- 2022-01-31 · Referred to the Subcommittee on Health.
Summary
Medical Innovation Acceleration Act of 2022
This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.
The bill defines noninvasive diagnostic device as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.